Cutaneous thrombosis associated with skin necrosis following Oxford-AstraZeneca COVID-19 vaccination

Clin Exp Dermatol. 2021 Dec;46(8):1610-1612. doi: 10.1111/ced.14819. Epub 2021 Jul 29.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Administration, Topical
  • Aged
  • Anti-Bacterial Agents / administration & dosage
  • Anti-Bacterial Agents / therapeutic use
  • Anti-Inflammatory Agents / administration & dosage
  • Anti-Inflammatory Agents / therapeutic use
  • Biopsy
  • COVID-19 / diagnosis
  • COVID-19 / epidemiology
  • COVID-19 / prevention & control*
  • COVID-19 / virology
  • ChAdOx1 nCoV-19 / adverse effects*
  • Clobetasol / administration & dosage
  • Clobetasol / therapeutic use
  • Combined Modality Therapy
  • Compression Bandages
  • Diagnosis, Differential
  • Humans
  • Male
  • Necrosis / diagnosis*
  • Necrosis / drug therapy
  • Necrosis / therapy
  • Neomycin / administration & dosage
  • Neomycin / therapeutic use
  • Nystatin / administration & dosage
  • Nystatin / therapeutic use
  • SARS-CoV-2 / genetics
  • SARS-CoV-2 / immunology
  • Skin / pathology
  • Skin Diseases / chemically induced
  • Skin Diseases / pathology*
  • Thrombosis / diagnosis*
  • Thrombosis / drug therapy
  • Thrombosis / therapy
  • Treatment Outcome

Substances

  • Anti-Bacterial Agents
  • Anti-Inflammatory Agents
  • Nystatin
  • Clobetasol
  • ChAdOx1 nCoV-19
  • Neomycin